Literature DB >> 10523367

Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group.

C Schettini1, M Bianchi, F Nieto, E Sandoya, H Senra.   

Abstract

Previous studies have reported results on 24-hour ambulatory blood pressure (ABP) in Europe and Japan, but no data exists from South America. In this study, we conducted a population survey to identify reference values and to compare ambulatory blood pressure with clinic, home, and self-measured values. A random sample of 2650 adults was selected among 190 000 people covered by our prepaid healthcare institution. Clinic (physician and nurse) and home (nurse) blood pressure measurements were performed 3 times each, with semiautomatic electronic equipment. Self-measurements were performed by the subjects manually activating the ambulatory device. We analyzed 1573 individuals who were not receiving antihypertensive therapy from 1921 participants. Self-measurement was available in a subgroup of 577 participants younger than the whole sample. Normal ambulatory blood pressure limits were estimated as those that best correlated with 140/90 mm Hg at clinic. Estimated values were 125/80 mm Hg for 24-hour ambulatory (range: 122 to 128 and 77 to 83 mm Hg) and 129/84 mm Hg for daytime ambulatory (range: 127 to 132 and 81 to 86) blood pressure, depending on gender and age. Ambulatory and clinic blood pressures increased with age. The age-dependent increase in ABP was similar in women and men. Average blood pressure at clinic was 124/79 mm Hg by physician and 123/78 mm Hg by nurse. Nurse measurement at home was 125/78 mm Hg, daytime ambulatory was 121/77 mm Hg, and 24-hour ambulatory was 118/74 mm Hg. The values of the subgroup with self-measurement were physician 119/77 mm Hg; nurse at clinic 118/77 mm Hg; nurse at home 121/78 mm Hg; self-measured 115/72 mm Hg; daytime ambulatory 119/77 mm Hg; and 24-hour ambulatory 115/73 mm Hg. This study shows that a 24-hour ABP average value of 125/80 mm Hg and a daytime ABP average value of 129/84 mm Hg are suitable upper limits for normality. Higher limits would yield an artificially higher prevalence of white coat hypertension. Most subjects showed higher blood pressure levels when measurements were performed by healthcare personnel at a clinic or at home than when self-measured at home.

Entities:  

Mesh:

Year:  1999        PMID: 10523367     DOI: 10.1161/01.hyp.34.4.818

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

1.  Prevalence and determinants of white coat effect in a large UK hypertension clinic population.

Authors:  O Thomas; K E Shipman; K Day; M Thomas; U Martin; I Dasgupta
Journal:  J Hum Hypertens       Date:  2015-09-17       Impact factor: 3.012

2.  Stenting the mildly obstructive aortic arch: useful treatment or oculo-inflatory reflex?

Authors:  K M English
Journal:  Heart       Date:  2006-07-03       Impact factor: 5.994

3.  RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension.

Authors:  Bruce E Blanchard; Gregory J Tsongalis; Margaux A Guidry; Lisa A LaBelle; Michelle Poulin; Amy L Taylor; Carl M Maresh; Joseph Devaney; Paul D Thompson; Linda S Pescatello
Journal:  Eur J Appl Physiol       Date:  2006-02-09       Impact factor: 3.078

4.  Diagnostic Thresholds for Blood Pressure Measured at Home in the Context of the 2017 Hypertension Guideline.

Authors:  Wanpen Vongpatanasin; Colby Ayers; Hamza Lodhi; Sandeep R Das; Jarett D Berry; Amit Khera; Ronald G Victor; Feng-Chang Lin; Anthony J Viera; Yuichiro Yano; James A de Lemos
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

5.  Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline.

Authors:  Paul Muntner; Robert M Carey; Kenneth Jamerson; Jackson T Wright; Paul K Whelton
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

6.  Relationship between office and home blood pressure with increasing age: The International Database of HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO).

Authors:  Angeliki Ntineri; George S Stergiou; Lutgarde Thijs; Kei Asayama; José Boggia; Nadia Boubouchairopoulou; Atsushi Hozawa; Yutaka Imai; Jouni K Johansson; Antti M Jula; Anastasios Kollias; Leonella Luzardo; Teemu J Niiranen; Kyoko Nomura; Takayoshi Ohkubo; Ichiro Tsuji; Christophe Tzourio; Fang-Fei Wei; Jan A Staessen
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

7.  Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.

Authors:  Joseph Ravenell; Daichi Shimbo; John N Booth; Daniel F Sarpong; Charles Agyemang; Danielle L Beatty Moody; Marwah Abdalla; Tanya M Spruill; Amanda J Shallcross; Adam P Bress; Paul Muntner; Gbenga Ogedegbe
Journal:  Circulation       Date:  2017-04-20       Impact factor: 29.690

8.  Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study.

Authors:  Joseph E Schwartz; Matthew M Burg; Daichi Shimbo; Joan E Broderick; Arthur A Stone; Joji Ishikawa; Richard Sloan; Tyla Yurgel; Steven Grossman; Thomas G Pickering
Journal:  Circulation       Date:  2016-12-06       Impact factor: 29.690

9.  Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.

Authors:  T W Hansen; L Thijs; Y Li; J Boggia; Y Liu; K Asayama; M Kikuya; K Björklund-Bodegård; T Ohkubo; J Jeppesen; C Torp-Pedersen; E Dolan; T Kuznetsova; K Stolarz-Skrzypek; V Tikhonoff; S Malyutina; E Casiglia; Y Nikitin; L Lind; E Sandoya; K Kawecka-Jaszcz; J Filipovský; Y Imai; J Wang; E O'Brien; J A Staessen
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

10.  Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.

Authors:  Geoffrey A Head; Anastasia S Mihailidou; Karen A Duggan; Lawrence J Beilin; Narelle Berry; Mark A Brown; Alex J Bune; Diane Cowley; John P Chalmers; Peter R C Howe; Jonathan Hodgson; John Ludbrook; Arduino A Mangoni; Barry P McGrath; Mark R Nelson; James E Sharman; Michael Stowasser
Journal:  BMJ       Date:  2010-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.